0001127602-21-001691.txt : 20210114
0001127602-21-001691.hdr.sgml : 20210114
20210114182523
ACCESSION NUMBER: 0001127602-21-001691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210114
DATE AS OF CHANGE: 20210114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SUGAR RONALD D
CENTRAL INDEX KEY: 0001216519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 21530036
MAIL ADDRESS:
STREET 1: 10877 WILSHIRE BLVD.
STREET 2: SUITE 1650
CITY: LOS ANGELES
STATE: CA
ZIP: 900274
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-01-13
0000318154
AMGEN INC
AMGN
0001216519
SUGAR RONALD D
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
Common Stock
2021-01-13
4
M
0
1000
71.64
A
16805
D
Common Stock
2021-01-13
4
S
0
1000
235.99
D
15805
D
Nqso (Right to Buy)
71.64
2021-01-13
4
M
0
1000
0
D
2013-04-27
2022-04-27
Common Stock
1000
4000
D
The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
These shares include 2,142 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
/s/ Ronald D. Sugar
2021-01-14